Stock UniverseDerived research view · source repositories remain read-only

MacroGenics, Inc. (MGNX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
21.03
Global Rank
3230
Market Cap
125.88M
Latest Close
3.91
RS Composite
77.83% · G#66

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
29.90%
3M
75.34%
6M
179.29%
1Y
160.67%
3Y
-16.27%
5Y
-87.85%
10Y
-84.70%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 559.35K · 30-day average: 1.19M · Max drawdown over stored range: -97.02%

Research Snapshot

Relative Strength vs SPX

RS Composite77.83%
20D RS32.36%
60D RS8.09%
120D RS170.31%
Global RS Rank66 · 98.03% percentile
Watch+Speculative RS Rank34 · 98.38% percentile
Group ScopeWatch+Speculative
Primary RS Rank10 · 97.82% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank423 / 701
Primary Percentile39.80
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for MGNX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue104.88377.447151.94158.749149.962149.5
Revenue Growth (YoY)63.4%-26.159%96.187%-61.334%155.259%-0.308%
Gross Profit-88.318-139.781-62.469-116.056-39.531
Operating Income-131.06-202.795-121.418-168.244-110.578
Free Cash Flow-117.804-150.031-90.582-79.969-72.079-82.954
Free Cash Flow Per Share-2.246-2.503-1.474-1.291-1.151-1.3134965387432869
EPS (Diluted) GAAP-2.473933-3.371689-1.949404-0.146263-1.069382
EPS Growth
EPS Non-GAAP
Gross Margin-84.206%-180.486%-41.114%-197.545%-26.361%75.9137%
Operating Margin-124.958%-261.85%-79.911%-286.378%-73.737%-48.7231%
Profit Margin-123.699%-260.972%-78.819%-15.418%-44.655%-49.913%
Free Cash Flow Margin-112.319%-193.721%-59.617%-136.12%-48.065%-55.4876%
Shares Outstanding (Diluted)52.442459.944761.433161.929262.621263.1551
Shares Change (YoY)9.067%14.306%2.483%0.808%1.117%0.853%

SEC Quarterly Fundamentals

No processed quarterly rows for MGNX.